Ann: IHL-675A outperforms existing treatment for arthritis, page-117

Cylon1 robust debate is fine and we all engage in that but we do not engage in BS with posters that have no clue about the fundamentals and value of a stock and blow hot air my friend .Perhaps you should read all the material on the company and understand the biotech /pharma space before forming a view as your comments are a nonsense . After you have read the huge amount of material which has resulted in the SP going from 1-2 c to where we are now you will understand why . Such rerates occur on fundamentals. Seriously bud do your research so you understand what you comment on .